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ABSTRACT
Objective: The aim of this study was to analyze antioxidant effect of geraniol (GE) in different in vitro models.
Methods: Initially, the antioxidant activity of GE was assessed by diphenyl picrylhydrazyl radical (DPPH) assay. The modulatory effect of GE against 
2,2’-azobis(2-amidinopropane) dihydrochloride induced lipid peroxidation in rat brain regions (cortex and cerebellum) and sciatic nerve (SN) 
homogenates was determined. Further, the effect of GE was assessed against hyperglycemia-induced oxidative stress (OS) in SHSY5Y, a human 
neuroblastoma cell line.
Results: GE proved to be a good scavenger of DPPH free radical (inhibitory concentration 50% [IC50] value = 663 nmol) and could lower the lipid 
peroxidation levels in rat brain tissue and SN homogenates (25-40%). Further, it rescued the SHSY5Y cells from hyperglycemia-induced death. Co-
exposure of GE with the IC50 level of glucose (100 mM) lowered the levels of reactive oxygen species, hydrogen peroxides and 3-nitrotyrosine levels 
with concomitant elevation in the glutathione levels (about two folds).
Conclusion: Collectively from these findings and other studies previously conducted (from our lab and others) emphasize the potential benefit of GE 
against oxidative stress (OS), a progressive pathological feature of neurodegenerative disorders.
Keywords: Geraniol, Antioxidant, In vitro studies, Diabetic neuropathy.
INTRODUCTION
Oxidative stress (OS) has been understood as one of the prominent 
features leading to the progression of diabetic neuropathy (DN) and 
other neurodegenerative disorders (NDD) [1,2]. Development of higher 
levels of reactive oxygen species (ROS) and reactive nitrogenous species 
(RNS) is evident in the nervous tissue in various NDD such as Alzheimer’s 
disease (AD) and Parkinson’s disease (PD). These reactive species 
include hydroxyl radical, superoxide, nitric oxide, hydrogen peroxide, 
and peroxynitrites. Overproduction of ROS/RNS, with a concomitant, 
compromised antioxidant defense system results in significant protein 
oxidation, lipid peroxidation and nucleic acid oxidation [1]. These 
oxidized molecules with hampered structure/function lead to various 
cellular processes including inflammatory response, mitochondrial 
dysfunction, and possibly apoptosis in NDD [2-4]. DN is a common 
neurodegenerative complication with no definite pharmacological 
solution because of its multifactorial etiology [5].
In this scenario, plant-derived compounds with multiple target might 
play a role in drug discovery and development. A number of studies 
have demonstrated potential health-promoting properties of natural 
products as therapeutics for NDD [6-8]. Several epidemiological reports 
have documented the influence of dietary habits on lower incidence 
of NDD. In particular, a significant positive correlation between the 
consumption of polyphenolic phytochemical-rich foods and the 
prevention of certain neurological diseases, has been emphasized. 
Many bioactives such as eugenol, bacopasides, withanolide, and 
curcumin have been investigated for their neuroprotective function in 
various NDD models [9-11].
Geraniol (GE) is a bioactive belonging to the class of 
monoterpenoids [12]. It is found as an important constituent of 
essential oils of various aromatic herbs. It has a pleasant aroma and 
is characteristic of rose oil and citrus fruits [12,13]. It is also found in 
differential amounts in several herbs such as coriander and allspice. It 
has applications due to its aroma in food and beverage industries as a 
flavoring agent. It is also found in a wide range of cleansing products 
and cosmetics for its appealing odor [13,14]. In the recent past, 
several studies have recognized the pharmacological potential of GE in 
different models [15-17]. Its pharmacological property is by virtue of 
its antioxidant and anti-inflammatory properties [18,19].
However, phytochemicals in general and polyphenols, in particular, 
can also exert pro-oxidant activities under certain experimental 
conditions [20]. To date, neither pro-oxidant nor antioxidant activities 
have yet been clearly established to occur in humans. The mechanism 
through which such dietary supplementation may diminish deleterious 
effects taking place during degenerative processes of a given disease 
is not clearly understood. In this study, an attempt has been made to 
investigate the antioxidant potential of GE in brain and sciatic nerve 
(SN) homogenates. This was followed by the investigation of the 
modulatory potency of GE in SHSY5Y, neuroblastoma cell line, under 
hyperglycemic condition simulating DN. These studies were designed 
based on the data pertaining to the modulatory effects of GE obtained 
in in vivo studies from the same lab earlier [16,21].
METHODS
GE, diphenyl picrylhydrazyl radical (DPPH), 2,2’-Azobis(2-
amidinopropane) dihydrochloride (AAPH), KRBS reagent, 
thiobarbituric acid (TBA), trichloroacetic acid, glacial acetic acid, 
sodium nitroprusside, Griess reagent, hydrogen peroxide, Lowry’s 
reagent, and FC reagent were purchased from Aldrich-Sigma and SRL. 
All other chemicals and solvents were of analytical grade and were 
purchased from local suppliers of manufacturers such as Merck, Hi-
media, Sigma and SRL.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Free radical scavenging potency of GE in chemical systems
The antioxidant potential of GE was assessed employing following 
in vitro methods as described earlier [9].
DPPH radical scavenging assay
The DPPH free radical scavenging assay was performed by incubating 
aliquots of GE (final concentration in the reaction mixture in the 
range of 0-1600 nmol) with 100 µL DPPH (0.1 mM) for 30 minutes. 
The absorbance was measured at 517 nm using an enzyme-linked 
immunosorbent assay plate reader (molecular devices E750). The assay 
was performed in three replicates for each concentration. The percent 
DPPH radical scavenged was calculated and expressed as inhibitory 
concentration 50% (IC50) value. IC50 value was calculated statistically 
using non-linear regression (dose vs. inhibition).
Modulatory effect of GE against AAPH-induced lipid peroxidation
Adult male rats were sacrificed using general anesthesia. Brain and 
SN were dissected and brain regions, viz., Ct and Cb were separated 
on ice. Ct and Cb were homogenized (10% w/v) separately in ice-
cold phosphate buffered saline (0.1 M, pH 7.4, 0.8% NaCl) centrifuged 
at 800 × g (10 minutes, 4°C) and the supernatant was collected and 
freshly used for the in vitro analysis. SN was minced and homogenized 
under ice in 0.1 M tris-HCl buffer of pH 7.4, and the cytosolic fraction 
was obtained by centrifuging the samples at 2,000 × g. Initially, tissue 
homogenates (Ct, Cb, and SN) were incubated (1 hr, 37°C) with AAPH 
(50, 100, and 200 µM) in vitro in a final volume of 500 µL made up 
using Krebs-Ringer bicarbonate solution as described earlier and the 
induction of lipid peroxidation was measured. To assess the potency 
of GE to inhibit AAPH-induced lipid peroxidation, tissue homogenates 
challenged with AAPH (50 µM) was co-incubated with or without 
different concentrations (50, 100, and 200 nmol) of GE for 1 hr. Separate 
GE aliquots were maintained without AAPH to monitor any per se effect. 
After the incubation period, the extent of formation of lipid peroxides 
was quantified as levels of malondialdehyde (MDA) by measuring TBA 
reactive substances.
Cell culture experiments: In vitro model of hyperglycemia in 
SHSY5Y cells
Induction of hyperglycemia
SHSY5Y, a human neuroblastoma cell line, was maintained in Dulbecco’s 
Modified Eagle’s Medium media supplemented with 10% fetal bovine 
serum and pens trep. The growth conditions include humid atmosphere of 
5% CO2 and 95% O2 at 37°C. Cells were plated in 96 well plates at a density 
of 5×105 cells/well. Cells were exposed to different concentrations of 
glucose (Glc; 25 - 300 mM) for 24 hrs. MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazoliumbromide] assay was carried out to determine 
cell survivability [22]. The yellow tetrazolium MTT gets reduced by 
metabolically active cells, in part by the action of dehydrogenase 
enzymes resulting in the formation of purple formazan crystals. These 
intracellular formazan crystals were then solubilized in SDS-DMF buffer 
(45% DMF in distilled water and 10% SDS, pH 4.7). It was quantified 
spectrophotometrically at 570 nm, and percent cell survivability was 
calculated against control (using OD as a measure).
Effect of GE on cell survivability
A 10 mM stock solution of GE was prepared in 95% ethanol, while all the 
working standards were prepared in the culture media. Initially, cells 
were plated in 96 well plates at a density of 5-105 cells/well containing 
different concentrations (1-100 µM) of GE for 24 hrs. Cell survival was 
determined by MTT assay to ascertain the non-toxic concentrations. For 
further experiments, only selected concentrations were employed, to 
assess the potential to modulate glucose-induced cellular aberrations 
and cell death.
Modulatory effects of GE on glucose-induced OS
SHSY5Y cells were co-exposed to sub-lethal concentrations of GE and 
100 mM of glucose (IC50 concentration) for 24 hrs. Cell survival and 
protection rendered by the active against glucose-induced cell death was 
determined by MTT assay. For biochemical estimations, experiments 
were carried out only with a functional concentration of 10 µM of GE 
(i.e., the concentration at which it rendered protection against glucose-
induced cell death). Selected markers for OS (generation of ROS, levels 
of hydroperoxides (HP) and glutathione [GSH]) were determined post 
24 hrs co-exposure.
Modulatory effect of GE on ROS levels
ROS generation was assayed using 2,7-dichloro-fluorescein diacetate 
(H2 DCFH-DA), a nonpolar compound, which after conversion to a polar 
derivative by intracellular esterases, rapidly reacts with ROS to form the 
highly fluorescent compound DCF [23]. Briefly, an aliquot (100 µg protein 
equivalent) was incubated in Locke’s buffer (pH 7.4; NaCl: 154 mM, KCl: 
5.6 mM, NaHCO3: 3.6 mM, HEPES: 5 mM, CaCl2: 2 mM, and glucose: 10 mM) 
containing H2DCFH-DA (5 mM) for 30 minutes at room temperature. The 
fluorescent product DCF formed was measured using a spectrofluorimeter 
with an excitation and emission wavelengths of 480 nm and 530 nm, 
respectively. The ROS generation was calculated from a DCF standard 
curve and expressed as nmol DCF/minutes/mg protein.
Modulatory effect of GE on HP levels
HP levels were measured according to a previously described method 
using FOX 1 reagent with minor modifications [24]. An aliquot of 
cytosolic (or mitochondrial) fraction (100 mg protein) was added to 
1 mL FOX reagent (100 µM xylenol orange; 250 µM ammonium ferrous 
sulfate; 100 µM sorbitol; 25 mM H2SO4) and incubated for 30 minutes 
at room temperature. The color developed was read at 560 nm in a 
spectrophotometer. The concentration of HP was calculated using the 
molar extinction coefficient (ε=2.2×105/M/cm) and expressed as nmol 
HP/mg protein.
Modulatory effect of GE on GSH levels
GSH content was quantified based on a fluorimetric method as 
described previously using ophthalaldehyde (OPT) [25]. Briefly, an 
aliquot of the cytosolic fraction was added to formic acid (0.1 M) and 
centrifuged at 10,000× g for 10 minutes. An aliquot of supernatant 
(deproteinized) was added to tubes containing buffered formaldehyde 
(1: 4 (v/v) 37% formalin: 0.1 M Na2HPO4). Sodium phosphate buffer 
(0.1 M; pH 8.0; containing 5 mM ethylenediaminetetraacetic acid) was 
added to each tube followed by OPT (100 µg/mL). Following incubation 
for 45 minutes at room temperature, the fluorescence was measured 
(excitation: 345 nm and emission: 425 nm). Concentration of GSH was 
calculated from a standard curve and values were expressed as nmol/
mg protein.
Modulatory effect of GE on nitrated proteins 3-nitrotyrosine 
(3-NT)
The extent of protein nitration was estimated in terms of 3NT employing 
a slot-blot method. In brief, aliquots (15 µg protein) were spotted in 
triplicates onto a nitrocellulose membrane. The membranes were 
treated with a blocking buffer containing 2% bovine serum albumin in 
PBS-Tween 20 (PBST) (PBS, 0.1 M, pH 7.4, containing 0.14 M NaCl, and 
0.01% Tween-20) for 60 minutes at room temperature and probed with 
polyclonal anti-3-NT antibody (1:500; origin- Rabbit; Sigma Chemical Co. 
USA.) over the next 60 minutes. The membranes were washed repeatedly 
in PBST and incubated with ALP-conjugated secondary antibody 
(1:3000; origin-goat; Merck- Bangalore Genei, India) for 60 minutes. The 
membranes were developed employing BCIP/NBT reaction. To adjust for 
protein loading, duplicate membranes were also immune-stained with 
Anti-β actin monoclonal antibody (1:2000; Sigma, USA). Optical density 
on the blots was measured with ImageJ Software (NIH, USA). The extent 
of protein nitration was expressed as arbitrary units [26].
RESULTS
Free radical scavenging effect of GE in chemical systems
DPPH radical scavenging assay
GE scavenged the free radical DPPH to a yellow colored 1,1-diphenyl-2-
picrylhydrazyl in a concentration-dependent manner (Fig. 1). The IC50 
value was found to be 663 nmol by statistical analysis (R2=0.9513).
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Modulatory effect of GE against AAPH-induced lipid peroxidation
AAPH exposure resulted in a concentration-dependent increase in 
lipid peroxidation in different tissues of rat (Data not shown). The 
elevated levels of MDA (indicative of lipid peroxidation) induced by 
50 µM AAPH in different tissues were - Ct: 67.7±6%; Cb: 90.8±3%; SN: 
69.4±9%. While GE reduced the extent of lipid peroxidation in Ct at 
all concentrations tested, in Cb and SN reduction was evident only at 
100 nmol concentrations (Fig. 2).
Cell culture experiments: In vitro model of hyperglycemia in 
SHSY5Y cells
Effect of glucose and GE on cell survivability
Exposure of SHSY5Y cells to different concentrations of glucose resulted 
in a concentration-dependent cell death as evidenced by MTT reduction 
assay. Based on these previous preliminary studies, for studying the 
modulatory potency of GE, glucose concentration of 100 mM (IC50) was 
used [27]. Further, exposure of cells to GE per se did not cause any cell 
death in the concentration range of 5-50 mM. Hence, the concentrations 
used for studying the modulatory potency of GE against hyperglycemia 
were in the range of 5-50 µM. GE offered protection (p≤0.05) only at the 
concentration of 10 µM (Fig. 3).
Modulatory effects of GE on glucose-induced OS
Glucose exposure caused significant induction of OS as evidenced by 
elevation in ROS (20%) and HP (50%) levels as well as depletion in 
GSH levels (35%) (Table 1). GE exposed cells exhibited a significant 
reduction in the endogenous levels of ROS (37%) and HP (27%). 
While ROS levels were reduced marginally by GE when co-exposed 
with glucose, the HP levels were normalized (Fig. 4a and b). While no 
alteration in the endogenous levels of GSH/GSSG with GE exposure was 
evident, on co-exposure with glucose, the GSH levels were increased 
two folds (Table 1).
Modulatory effects of GE on 3-NT levels
Glucose exposure to SHSY5Y cells resulted in a marked increase (46%) 
in 3-NT levels. While GE reduced the endogenous levels moderately, a 
marked diminution (about three-fold against glucose per se) occurred 
when co-exposed with glucose (Fig. 5).
DISCUSSION
The complexity of biochemical pathways in central nervous system 
and peripheral nervous system in NDD is not fully understood. 
Nevertheless, OS and inflammatory reactions play a central role in 
degenerative processes. This necessitates to target the increase in OS by 
supplementing with antioxidants and/or to fortify antioxidant defense 
system to keep a check on the progression of different degenerative 
pathways. This is true of neurodegeneration seen in the case of AD, 
PD or DN. Several labs including ours have been investigating the 
possibilities of employing plant based actives against NDD [9-11,28]. 
The mechanisms through which supplementation of such bioactives 
may diminish free radical-related diseases like NDD is associated to 
their multiple biological abilities. This includes their ability to reduce 
the levels of or the formation of ROS and RNS, concomitantly up-
regulating vitagenes, such as members of the heat shock protein (Hsp) 
family, heme oxygenase-1, and Hsp70 [8,26].
GE has been reported as an effective antioxidant and anti-
inflammatory agent in different experimental models from our lab and 
others [16-19,21,29]. Recently, the antioxidant activity of GE along with 
other actives has been published with respect to DPPH free radical 
scavenging activity and superoxide dismutase activity [30]. However, 
Fig. 1: Free radical scavenging activity of geraniol as determined 
by diphenyl picrylhydrazyl radical scavenging assay. Values are 
mean ± SE (n=3 replicates/concentration, from two independent 
experiments)
Fig. 2: Effect of geraniol on 2,2′-azobis(2-methylpropionamidine) 
(APPH) induced lipid peroxidation in cortex (a), cerebellum 
(b) and sciatic nerve (c) of male Wistar rats. Values are mean 
± SE (n=3 replicates/concentration, from two independent 
experiments). Data analyzed by one-way analysis of variance 
followed by Tukey’s test for comparison of means. *Significant 
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this study was planned and executed bearing in mind our results in 
different experimental models of neurodegeneration [16,21]. These 
studies emphasized the modulatory potency of oral supplementation of 
GE against acrylamide induced neurotoxicity and DN. In both the in vivo 
studies, it was evident that GE supplementation could interfere with 
OS by altering the levels of oxidative markers such as ROS, hydrogen 
peroxides, nitrites and protein carbonyls in brain regions, and SN. 
Hence in this study, first the DPPH free radical scavenging capacity was 
determined and was found to be concentration dependent (correlation: 
R2 = 0.9513). Further, the homogenates of Ct, Cb, and SN were 
challenged with AAPH leading to the induction of lipid peroxidation in 
these high lipid containing nervous tissues. This mimics the condition 
of high lipid peroxidation levels noted in NDD. The modulatory 
potential of GE against AAPH induced lipid peroxidation was clearly 
evident by the reduced levels of MDA in all tissue homogenates tested. 
This emphasizes the role of GE to reduce lipid peroxidation in the in vivo 
models studied earlier.
Further, experiments were carried out in media containing high levels 
of glucose in the SHSY5Y undifferentiated cells simulating diabetic 
condition. In the case of neuronal cells the glucose uptake is facilitated 
diffusion, and hence whenever the blood glucose levels are high as is 
the case of diabetes, the neuronal glucose level is elevated [31,32]. 
Hyperglycemia leads to the activation of various glucose-mediated 
pathways such as polyol pathway, AGE formation pathway, activation of 
protein kinase A and hexosamine monophosphate pathway ultimately 
culminating to the development of OS, inflammatory reactions and 
apoptotic process [2,33]. In SHSY5Y cells, hyperglycemic condition 
induced cell death and elevation in OS markers such as ROS, hydrogen 
peroxides, and 3-nitrotyrosine [27,34]. GE co-exposure with the IC50 
level of glucose rescued the cells from death. Further, enhanced levels 
of ROS and hydrogen peroxide were significantly reduced with GE 
clearly suggesting its ability to interfere OS related mechanism under 
high glucose levels. Interestingly, GE also enhanced the depleted 
levels of GSH with concomitant change (about 20%) in the levels of 
GSSG (Data not shown). This is in line with our previous findings in 
streptozotocin model of diabetes in rat where GE significantly altered 
the oxidative markers in different regions of the brain and SN [16]. 
Further, antioxidant effect is a key feature which is being investigated 
by several diabetes researchers and hunt for novel phytochemicals 
alone or in the form of extracts is going on worldwide [32,35].
CONCLUSION
In this study, the in vitro analysis employing various models exhibited 
the antioxidant activity of GE. These findings and studies from other 
labs further emphasizes the potential of GE against free radical 
mediated deleterious effects under various disease conditions like 
NDD [18,31,36]. GE is hence proposed to be employed as an adjuvant 
in the management or prevention of neurodegenerative processes 
involved in NDD like DN.
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Table 1: Modulatory effect of geraniol (GE 10 µM) on reduced 
GSH in SHSY5Y cells co-exposed with glucose (Glc, 100 mM) for 
24 hrs
Group GSH (nmol/ mg protein)
Control 22.28±0.7
GE 10 µM 22.52±1.2
Glc 100 mM 14.92±0.8*
Glc + GE 10 µM 29.16±0.3#
GSH: Glutathione, Data analyzed by one-way analysis of variance followed by 
Tukey’s test for comparison of means. *significant against control, #against 
glucose (Glc, 100mM), p≤0.001
Fig. 3: Modulatory effect of geraniol (GE 5, 10 and 20 µM) on 
co-exposure with glucose (Glc, 100 mM) in SHSY5Y cells for 24 
hrs; values are mean ± SE (3 sets of experiments). Data analyzed 
by one-way analysis of variance followed by Tukey’s test for 
comparison of means. *Significant p<0.05 against glucose 
(Glc, 100 mM)
Fig. 4: Modulatory effect of geraniol (GE 10 µM) on reactive oxygen species (a) and hydroperoxides (b) when co-exposed with glucose 
(Glc, 100 mM) in SHSY5Y cells for 24 hrs. Values are mean ± SE (3 sets of experiments). Data analyzed by one-way analysis of variance 
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Fig. 5: Modulatory effect of geraniol (GE, 10 µM) on the levels 
of 3-nitrotyrosine in SHSY5Y cells co-exposed with glucose 
(Glc, 100 mM) for 24 hrs as evidenced by slot blot analysis. Values 
are mean ± SE (3 sets of experiments). Data analyzed by one-way 
analysis of variance followed by Tukey’s test for comparison of 
means. *Significant (p<0.05) against Control and # significant 
(p<0.05) against glucose (Glc, 100mM)
